Ascendis pharma a/s (ASND)
Income statement / Yearly
Dec'17Dec'16Dec'15
Other comprehensive income / (loss)
Items that may be reclassified subsequently to profit or loss:
Number of shares used for calculation (basic and diluted)

33,626

26,564

23,766

Number of shares used for calculation (diluted)

33,626

26,564

23,766